Dalian BIO-CHEM Company Limited (SHA:603360)
20.60
+0.05 (0.24%)
Apr 29, 2026, 3:00 PM CST
Dalian BIO-CHEM Company Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14,403 | 22,582 | 10,998 | 3,732 | 4,451 | 3,334 | Upgrade
|
| Market Cap Growth | -3.93% | 105.32% | 194.70% | -16.15% | 33.48% | -16.39% | Upgrade
|
| Enterprise Value | 15,244 | 23,522 | 10,736 | 3,361 | 4,263 | 3,506 | Upgrade
|
| Last Close Price | 20.55 | 32.22 | 15.55 | 5.09 | 5.73 | 4.25 | Upgrade
|
| PE Ratio | 81.73 | 107.65 | 31.86 | 11.37 | 11.06 | 13.31 | Upgrade
|
| Forward PE | 47.79 | 10.46 | 10.46 | 10.46 | 11.95 | 13.57 | Upgrade
|
| PS Ratio | 9.61 | 13.10 | 8.39 | 3.50 | 3.54 | 3.31 | Upgrade
|
| PB Ratio | 7.01 | 11.08 | 4.68 | 2.28 | 3.05 | 3.18 | Upgrade
|
| P/TBV Ratio | 13.60 | 21.85 | 7.74 | 2.34 | 3.14 | 3.48 | Upgrade
|
| P/FCF Ratio | 26.74 | 44.28 | 124.88 | 11.58 | 12.88 | - | Upgrade
|
| P/OCF Ratio | 24.98 | 41.31 | 67.48 | 9.58 | 9.27 | 23.48 | Upgrade
|
| EV/Sales Ratio | 10.17 | 13.64 | 8.19 | 3.15 | 3.39 | 3.49 | Upgrade
|
| EV/EBITDA Ratio | 36.74 | 50.86 | 23.16 | 7.64 | 8.25 | 9.93 | Upgrade
|
| EV/EBIT Ratio | 49.51 | 63.73 | 27.19 | 8.93 | 9.57 | 11.50 | Upgrade
|
| EV/FCF Ratio | 28.30 | 46.12 | 121.91 | 10.43 | 12.34 | - | Upgrade
|
| Debt / Equity Ratio | 0.70 | 0.66 | 0.24 | 0.09 | 0.09 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 3.48 | 2.86 | 1.22 | 0.34 | 0.25 | 0.96 | Upgrade
|
| Debt / FCF Ratio | 2.68 | 2.64 | 6.45 | 0.47 | 0.37 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.06 | -0.04 | -0.27 | -0.20 | 0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.49 | 0.25 | -0.22 | -1.02 | -0.56 | 0.13 | Upgrade
|
| Net Debt / FCF Ratio | 0.37 | 0.22 | -1.14 | -1.39 | -0.84 | -0.89 | Upgrade
|
| Asset Turnover | 0.38 | 0.46 | 0.47 | 0.58 | 0.73 | 0.65 | Upgrade
|
| Inventory Turnover | 0.95 | 1.12 | 1.33 | 2.69 | 3.35 | 3.80 | Upgrade
|
| Quick Ratio | 1.62 | 1.64 | 1.10 | 3.67 | 3.40 | 0.91 | Upgrade
|
| Current Ratio | 2.86 | 2.87 | 2.26 | 4.70 | 4.36 | 1.36 | Upgrade
|
| Return on Equity (ROE) | 10.95% | 13.99% | 18.00% | 21.20% | 32.06% | 24.58% | Upgrade
|
| Return on Assets (ROA) | 4.87% | 6.12% | 8.84% | 12.73% | 16.26% | 12.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.16% | 14.56% | 19.89% | 27.15% | 34.31% | 25.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.20% | 12.40% | 15.60% | 22.50% | 29.40% | 26.90% | Upgrade
|
| Earnings Yield | 1.20% | 0.93% | 3.14% | 8.80% | 9.04% | 7.51% | Upgrade
|
| FCF Yield | 3.74% | 2.26% | 0.80% | 8.64% | 7.77% | -1.49% | Upgrade
|
| Dividend Yield | 1.88% | - | 2.76% | 6.02% | 5.09% | - | Upgrade
|
| Payout Ratio | 193.26% | 158.05% | 64.77% | 63.00% | 1.61% | 63.48% | Upgrade
|
| Buyback Yield / Dilution | 1.57% | 1.63% | -2.04% | -0.64% | 0.30% | 3.01% | Upgrade
|
| Total Shareholder Return | 3.45% | 1.63% | 0.71% | 5.38% | 5.39% | 3.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.